In 2019, they will test in a human vaccine against HIV

HIV vaccine will be tested in humans in 2019 after positive results in tests with laboratory mice.

Read also: Pedicure with fish could spread HIV and hepatitis C

A group of researchers from the National Institute of Allergy and Infectious Diseases of the United States, published in the scientific journal Nature , who already have enough information to start a human test phase .

According to its publication, it is planned to apply the vaccine against the human immunodeficiency virus (HIV) to by the end of 2019 .

The objective is to know the efficacy of the vaccine in humans, after the same component obtained neutralized several strains of HIV in animals of .

It is thought that the experimental vaccine might have a high probability of success in the fight against AIDS, since it attacks vulnerable regions of the HIV strain to completely neutralize it and prevent development. of the disease.

Colorful microscopic sample of HIV-1 attached to a lymphocyte (Wikimedia Commons).

This is at least what researchers think will happen once the vaccine will be tested in humans because of

Those who are responsible for the vaccine are optimistic as to the potency of the vaccine, as it showed high efficiency in most tests ] as part of the search procedure

In Nature magazine where the announcement was published , it was clarified that the creation of the vaccine occurred after the specialists realized identify antibodies able to neutralize the strains of HIV and then obtain them with an immunization based on the structure of a surface protein of the virus, which increases its effectiveness.

From now on, the doctors responsible for the vaccine will focus on improving the formula, as well as by making it safer for use in humans .

It is expected that once it is successfully tested in people, the vaccine will be marketed in the future shut down and help relieve the millions of people who are currently HIV-positive.